These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3349334)

  • 1. Fate of the ischaemic limb in Buerger's disease.
    Ohta T; Shionoya S
    Br J Surg; 1988 Mar; 75(3):259-62. PubMed ID: 3349334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
    Isner JM; Baumgartner I; Rauh G; Schainfeld R; Blair R; Manor O; Razvi S; Symes JF
    J Vasc Surg; 1998 Dec; 28(6):964-73; discussion 73-5. PubMed ID: 9845647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Course of Buerger's Disease.
    Ohta T; Ishibashi H; Sugimoto I; Iwata H; Kawanishi J; Yamada T; Tadakoshi M; Hida N
    Ann Vasc Dis; 2008; 1(2):85-90. PubMed ID: 23555344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).
    Modaghegh MS; Hafezi S
    Vasc Endovascular Surg; 2018 Feb; 52(2):124-130. PubMed ID: 29237360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal ischemia with digital gangrene secondary to Buerger's disease.
    Lance BJ; Kirschenbaum SE
    J Foot Surg; 1991; 30(6):534-41. PubMed ID: 1770204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of omental transfer in Buerger's disease: New Delhi's experience.
    Singh I; Ramteke VK
    Aust N Z J Surg; 1996 Jun; 66(6):372-6. PubMed ID: 8678856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buerger's disease: diagnosis and management.
    Shionoya S
    Cardiovasc Surg; 1993 Jun; 1(3):207-14. PubMed ID: 8076031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buerger's disease and cigarette smoking in Bangladesh.
    Grove WJ; Stansby GP
    Ann R Coll Surg Engl; 1992 Mar; 74(2):115-7; discussion 118. PubMed ID: 1567129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
    Fiessinger JN; Schäfer M
    Lancet; 1990 Mar; 335(8689):555-7. PubMed ID: 1689791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.
    Rodoplu O; Yildiz CE; Oztas DM; Conkbayir C; Unal O; Ulukan MO; Meric M; Ugurlucan M; Kirbas A
    J Invasive Cardiol; 2020 Jun; 32(6):E158-E167. PubMed ID: 32479418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombangiitis obliterans (Buerger's disease): still a limb threatening disease.
    Van Damme H; De Leval L; Creemers E; Limet R
    Acta Chir Belg; 1997 Oct; 97(5):229-36. PubMed ID: 9394964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buerger's disease in Hong Kong: a review of 89 cases.
    Lau H; Cheng SW
    Aust N Z J Surg; 1997 May; 67(5):264-9. PubMed ID: 9152156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the long-term outcome of Buerger's disease (thromboangiitis obliterans).
    Shigematsu H; Shigematsu K
    Int Angiol; 1999 Mar; 18(1):58-64. PubMed ID: 10392482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment for Buerger's disease.
    Cacione DG; Macedo CR; do Carmo Novaes F; Baptista-Silva JC
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011033. PubMed ID: 32364620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme distal bypass to improve wound healing in Buerger's disease.
    De Caridi G; Massara M; Villari S; Martelli E; Spinelli F; Grande R; Butrico L; de Franciscis S; Serra R
    Int Wound J; 2016 Feb; 13(1):97-100. PubMed ID: 24612761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger's disease).
    Wysokinski WE; Kwiatkowska W; Sapian-Raczkowska B; Czarnacki M; Doskocz R; Kowal-Gierczak B
    Angiology; 2000 Feb; 51(2):141-50. PubMed ID: 10701722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buerger's disease in the modern era.
    Mills JL; Taylor LM; Porter JM
    Am J Surg; 1987 Jul; 154(1):123-9. PubMed ID: 3605510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment for Buerger's disease.
    Cacione DG; Baptista-Silva JC; Macedo CR
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011033. PubMed ID: 26828199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Transpedal Retrograde Approach in Endovascular Treatment of Patients With Buerger's Disease.
    Tatli E; Buturak A; Vatan MB; Kurt Ömürlü I; Erkin A
    J Invasive Cardiol; 2023 Feb; 36(2):E84-E91. PubMed ID: 36562796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.